⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Risedronate

ریزدرونات

⚠ Unverified

🦴 Musculo-Skeletal SystemBisphosphonate

🤰 Pregnancy:Dangerous / avoid 👶 Children:Safety not established 👴 Older adults:Use with caution ⚥ Females & males of reproductive potential:Use with caution 🇮🇷 Registered in Iran ⛔ 1 contraindications 🇺🇸 FDA authorized generic NDA022560 ATC M05BA07

Market / country: 🇺🇸 USA

Atelvia (US)

🧮 Dose calculator

Disease / regimen

Osteoporosis / calcium and vitamin D deficiency · Regimen source: FDA Risedronate DR · 2.1 FDA Risedronate DR · 2.2

⛔ Once WEEKLY (not daily): one 35 mg tablet in the morning right after breakfast with at least 4 oz water; stay upright 30 min. Calcium and vitamin D if intake is inadequate. FDA Risedronate DR · 2.1 FDA Risedronate DR · 2.2

🛡️ Safety & information

Contraindications

⛔ Oesophageal abnormalities delaying emptying (stricture, achalasia); inability to stay upright 30 min; hypocalcaemia; hypersensitivity. FDA Risedronate DR · 4

Formulations

35 mg delayed-release tablet — tablet 🇺🇸 USA FDA Risedronate DR · 3

👥 Special populations

🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Risedronate DR · 8.1
“Discontinue Risedronate sodium delayed-release when pregnancy is recognized.”
🤱 BreastfeedingNo data
The source for this drug has no section for this group.
👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Risedronate DR · 8.4
“Risedronate sodium delayed-release is not indicated for use in pediatric patients.”
👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Risedronate DR · 8.5
“Of the patients receiving Risedronate sodium delayed-release in postmenopausal osteoporosis studies, 59% were 65 and over, while 13% were 75 and over.”
⚥ Females & males of reproductive potentialUse with caution
Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Risedronate DR · 8.3
“Infertility There are no data available in humans.”

🔗 Reference links

FDA (approval record)NDA022560
DailyMed (FDA label)FDA Risedronate DR
MedlinePlus (NIH)Risedronate
WHO ATC/DDDM05BA07
Darooyab (Iran)Risedronate

🇮🇷 Registered in Iran Darooyab · G-1444/Risedronate

Dosage forms with Iranian generic codes, per Darooyab.

08431 · RISEDRONATE 20MG TAB · قرص ریزدرونات ۲۰ میلی‌گرم
06737 · RISEDRONATE 30MG TAB · قرص ریزدرونات ۳۰ میلی‌گرم
06104 · RISEDRONATE 35MG TAB · قرص ریزدرونات ۳۵ میلی‌گرم
07662 · RISEDRONATE 5MG TAB · قرص ریزدرونات ۵ میلی‌گرم

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Risedronate DR · 3 FDA Risedronate DR · 2.1 FDA Risedronate DR · 2.2 FDA Risedronate DR · 4 FDA Risedronate DR · SPL approval / marketing category FDA Risedronate DR · 8.1 FDA Risedronate DR · 8.4 FDA Risedronate DR · 8.5 FDA Risedronate DR · 8.3
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · G-1444/Risedronate
Clinical review⚠ Unverified

🔗 Similar drugs

Same class

Alendronate

For the same diseases

Calcium carbonate + vitamin D3 Denosumab (Prolia)Raloxifene Zoledronic acid (yearly)